Name:	O
___.	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
CARDIOTHORACIC	O
Allergies:	O
Percocet	O
/	O
Atorvastatin	O
/	O
alprazolam	O
/	O
oxytocin	O
/	O
Demerol	O
/	O
Codeine	O
/	O
lorazepam	O
/	O
Cyclobenzaprine	O
/	O
narcotic	O
pain	O
medication	O
/	O
amiodarone	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Dyspnea	O
on	O
Exertion	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___	O
1.	O
Redo	O
sternotomy.	O
2.	O
Mitral	O
valve	O
replacement	O
with	O
a	O
___	O
tissue	O
valve,	O
serial	O
#___,	O
reference	O
___.	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
female	O
who	O
is	O
followed	O
by	O
Dr.	O
___	O
in	O
the	O
heart	O
failure	O
clinic	O
for	O
systolic	O
congestive	O
heart	O
failure,	O
infarct	O
related	O
cardiomyopathy,	O
LVEF	O
35%	O
with	O
___	O
MR.	O
___	O
has	O
a	O
history	O
of	O
CAD	O
s/p	O
CABG	O
___	O
LIMA-LAD,	O
SVG-D1,	O
SVG-OM1),	O
s/p	O
AICD	O
-	O
BiV	O
pacer	O
___,	O
afib,	O
DM,	O
PVD,	O
and	O
CKD.	O
She	O
remains	O
in	O
___	O
Functional	O
Class	O
III	O
and	O
continues	O
to	O
experience	O
significant	O
dyspnea	O
on	O
exertion	O
and	O
orthopnea.	O
Given	O
the	O
progression	O
of	O
her	O
symptoms	O
and	O
reaching	O
the	O
limits	O
of	O
medical	O
therapy,	O
cardiac	O
surgery	O
is	O
now	O
consulted	O
for	O
mitral	O
and	O
tricuspid	O
valve	O
repair	O
vs.	O
replacement.	O
Past	O
Medical	O
History:	O
-	O
Systolic	O
congestive	O
heart	O
failure	O
___:	O
EF	O
35%	O
-	O
Mitral	O
regurgitation	O
___	O
-	O
Coronary	O
artery	O
disease,	O
NSTEMI	O
___	O
s/p	O
CABG	O
x	O
___,	O
s/p	O
multiple	O
PCIs,	O
mostly	O
to	O
LAD	O
*	O
___:	O
NSTEMI	O
s/p	O
coronary	O
atherectomies	O
to	O
LAD/D1	O
bifurcation	O
lesion	O
with	O
placment	O
of	O
2	O
stents	O
and	O
PTCA	O
to	O
jailed	O
D1	O
*	O
___:	O
Elective	O
cath	O
revealed	O
in-stent	O
restenosis	O
and	O
90%D1	O
restenosis;	O
PTCRA	O
was	O
performed	O
for	O
in-stent	O
restenosis	O
as	O
well	O
as	O
kissing	O
balloons	O
to	O
LAD/D1	O
with	O
residual	O
20%	O
D1	O
lesion	O
*	O
___:	O
UA	O
with	O
cath/no	O
intervention	O
but	O
LVEDP	O
38	O
*	O
___:	O
Chest	O
pain	O
with	O
diagnostic	O
cath	O
showing	O
widely	O
patent	O
LIMA-LAD	O
and	O
SVG-D1-OM1.	O
LMCA	O
with	O
50%	O
stenosis,	O
LAD	O
with	O
80%	O
proximal	O
and	O
mid,	O
LCx	O
with	O
70-80%	O
proximal,	O
and	O
RCA	O
with	O
80%	O
ostial	O
lesion.	O
LVEDP	O
severely	O
elevated	O
to	O
36	O
mmHg.	O
*	O
RHC	O
on	O
___	O
showed	O
mean	O
wedge	O
of	O
20	O
and	O
CO	O
of	O
2.871	O
L/min	O
-	O
PACING/ICD:	O
-	O
___	O
Hx	O
NSVT	O
on	O
telemetry	O
in	O
the	O
setting	O
of	O
MI,	O
sustained	O
T-wave	O
alternans	O
on	O
stress	O
testing	O
(worked	O
up	O
for	O
ICD	O
but	O
none	O
placed)	O
-	O
s/p	O
AICD	O
-	O
BiV	O
pacer	O
___	O
-	O
Chronic	O
atrial	O
fibrillation,	O
on	O
Coumadin	O
-	O
Peripheral	O
vascular	O
disease	O
-	O
Diabetes	O
mellitus	O
-	O
Hypothyroidism	O
-	O
Nephrolithiasis	O
(s/p	O
right	O
nephrectomy,	O
creatinine	O
1.1-1.4	O
baseline)	O
-	O
Plantar	O
fasciitis	O
-	O
Reflux	O
esophagitis,	O
peptic	O
ulcer	O
disease,	O
GERD	O
-	O
GI	B-Lower_gastrointestinal_haemorrhage
Bleed	B-Lower_gastrointestinal_haemorrhage
___	O
-	O
Peripheral	O
neuropathy	O
Past	O
Surgical	O
History:	O
-	O
s/p	O
CABG	O
x	O
___	O
-	O
s/p	O
right	O
nephrectomy	O
-	O
s/p	O
AICD	O
-	O
BiV	O
pacer	O
___	O
-	O
s/p	O
right	O
inguinal	O
hernia	O
operations	O
x	O
___	O
-	O
s/p	O
laparoscopic	O
cholecystectomy	O
___	O
___)	O
-	O
s/p	O
hysterectomy	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
had	O
CHF,	O
died	O
at	O
age	O
___.	O
Otherwise	O
no	O
signficant	O
family	O
history	O
of	O
early	O
MI,	O
arrhythmia,	O
cardiomyopathies,	O
or	O
sudden	O
cardiac	O
death.	O
Physical	O
Exam:	O
Discharge	O
Exam:	O
VS:	O
T:	O
98.9	O
HR:	O
75	O
VP	O
BP:	O
___	O
Sats:	O
97%	O
RA	O
Wt:	O
77	O
Kg,	O
BS:	O
95-129	O
General:	O
___	O
year-old	O
female	O
in	O
no	O
apparent	O
distress	O
HEENT:	O
mucus	O
membranes	O
moist	O
Cardiac:	O
VPaced	O
normal	O
S1,S2	O
Resp:	O
clear	O
breath	O
sounds	O
throughout	O
GI:	O
benign	O
Extr:	O
warm	O
no	O
edema	O
Sternal:	O
incision	O
clean	O
dry,	O
intact,	O
no	O
erythema.	O
no	O
sternal	O
click	O
Neuro:	O
awake,	O
alert	O
oriented,	O
Moves	O
independently	O
Pertinent	O
Results:	O
Discharge	O
Labs	O
___	O
WBC-7.5	O
RBC-3.16*	O
Hgb-9.7*	O
Hct-30.8*	O
MCV-97	O
MCH-30.5	O
MCHC-31.4	O
RDW-15.5	O
Plt	O
Ct-89*	O
___	O
Glucose-124*	O
UreaN-38*	O
Creat-2.1*	O
Na-140	O
K-3.5	O
Cl-101	O
HCO3-31	O
___	O
UreaN-34*	O
Creat-2.7*	O
Na-142	O
K-4.7	O
Cl-105	O
___	O
Glucose-154*	O
UreaN-33*	O
Creat-2.6*	O
Na-140	O
K-4.2	O
Cl-102	O
HCO3-30	O
___	O
Glucose-78	O
UreaN-37*	O
Creat-2.2*	O
Na-142	O
K-3.1*	O
Cl-101	O
HCO3-34	O
___	O
Mg-2.5	O
___	O
___	O
PTT-31.8	O
___	O
___	O
___	O
PTT-30.7	O
___	O
___	O
___	O
PTT-29.1	O
___	O
___	O
___	O
PTT-33.1	O
___	O
___	O
___	O
PTT-34.2	O
___	O
Admission	O
Labs:	O
___	O
MRSA	O
SCREEN	O
(Final	O
___:	O
No	O
MRSA	O
isolated.	O
___	O
WBC-18.6*#	O
RBC-3.24*#	O
Hgb-9.9*#	O
Hct-31.2*#	O
MCV-96	O
MCH-30.7	O
MCHC-31.9	O
RDW-15.5	O
Plt	O
___	O
___	O
___	O
PTT-30.2	O
___	O
___	O
UreaN-30*	O
Creat-2.2*	O
Na-140	O
K-2.7*	O
Cl-106	O
HCO3-21	O
___	O
ALT-18	O
AST-56*	O
AlkPhos-89	O
Amylase-19	O
TotBili-0.4	O
Echocardiogram	O
___	O
Multiplanar	O
reconstructions	O
were	O
generated	O
and	O
confirmed	O
on	O
an	O
independent	O
workstation.	O
LEFT	O
ATRIUM:	O
Marked	O
___.	O
Mild	O
spontaneous	O
echo	O
contrast	O
in	O
the	O
body	O
of	O
the	O
___.	O
Depressed	O
___	O
emptying	O
velocity	O
(<0.2m/s)	O
All	O
four	O
pulmonary	O
veins	O
identified	O
and	O
enter	O
the	O
left	O
atrium.	O
RIGHT	O
ATRIUM/INTERATRIAL	O
SEPTUM:	O
Mildly	O
dilated	O
RA.	O
A	O
catheter	O
or	O
pacing	O
wire	O
is	O
seen	O
in	O
the	O
RA.	O
No	O
ASD	O
by	O
2D	O
or	O
color	O
Doppler.	O
LEFT	O
VENTRICLE:	O
Severely	O
dilated	O
LV	O
cavity.	O
Severely	O
depressed	O
LVEF.	O
RIGHT	O
VENTRICLE:	O
Mildly	O
dilated	O
RV	O
cavity.	O
Borderline	O
normal	O
RV	O
systolic	O
function.	O
AORTA:	O
Normal	O
aortic	O
diameter	O
at	O
the	O
sinus	O
level.	O
Simple	O
atheroma	O
in	O
aortic	O
root.	O
Normal	O
ascending	O
aorta	O
diameter.	O
Simple	O
atheroma	O
in	O
ascending	O
aorta.	O
Mildly	O
dilated	O
descending	O
aorta.	O
Simple	O
atheroma	O
in	O
descending	O
aorta.	O
AORTIC	O
VALVE:	O
Three	O
aortic	O
valve	O
leaflets.	O
Moderately	O
thickened	O
aortic	O
valve	O
leaflets.	O
Filamentous	O
strands	O
on	O
the	O
aortic	O
leaflets	O
c/with	O
Lambl's	O
excresences	O
(normal	O
variant).	O
No	O
AS.	O
No	O
AR.	O
MITRAL	O
VALVE:	O
Moderately	O
thickened	O
mitral	O
valve	O
leaflets.	O
Moderate	O
thickening	O
of	O
mitral	O
valve	O
chordae.	O
Severe	O
(4+)	O
MR.	O
___	O
VALVE:	O
Mildly	O
thickened	O
tricuspid	O
valve	O
leaflets.	O
No	O
TS.	O
Moderate	O
[2+]	O
TR.	O
PULMONIC	O
VALVE/PULMONARY	O
ARTERY:	O
Normal	O
pulmonic	O
valve	O
leaflet.	O
No	O
PS.	O
Physiologic	O
PR.	O
PERICARDIUM:	O
No	O
pericardial	O
effusion.	O
Conclusions	O
PRE-BYPASS:	O
The	O
left	O
atrium	O
is	O
markedly	O
dilated.	O
Mild	O
spontaneous	O
echo	O
contrast	O
is	O
seen	O
in	O
the	O
body	O
of	O
the	O
left	O
atrium.	O
The	O
left	O
atrial	O
appendage	O
emptying	O
velocity	O
is	O
depressed	O
(<0.2m/s).	O
No	O
atrial	O
septal	O
defect	O
is	O
seen	O
by	O
2D	O
or	O
color	O
Doppler.	O
The	O
left	O
ventricular	O
cavity	O
is	O
severely	O
dilated.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
(LVEF=	O
___	O
%).	O
The	O
right	O
ventricular	O
cavity	O
is	O
mildly	O
dilated	O
with	O
borderline	O
normal	O
free	O
wall	O
function.	O
There	O
are	O
simple	O
atheroma	O
in	O
the	O
aortic	O
root.	O
There	O
are	O
simple	O
atheroma	O
in	O
the	O
ascending	O
aorta.	O
The	O
descending	O
thoracic	O
aorta	O
is	O
mildly	O
dilated.	O
There	O
are	O
simple	O
atheroma	O
in	O
the	O
descending	O
thoracic	O
aorta.	O
There	O
are	O
three	O
aortic	O
valve	O
leaflets.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened.	O
There	O
are	O
filamentous	O
strands	O
on	O
the	O
aortic	O
leaflets	O
consistent	O
with	O
Lambl's	O
excresences	O
(normal	O
variant).	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
moderately	O
thickened.	O
There	O
is	O
moderate	O
thickening	O
of	O
the	O
mitral	O
valve	O
chordae.	O
Severe	O
(4+)	O
mitral	O
regurgitation	O
is	O
seen.	O
The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
Moderate	O
[2+]	O
tricuspid	O
regurgitation	O
is	O
seen.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
Brief	O
Hospital	O
Course:	O
Mrs.	O
___	O
was	O
brought	O
to	O
the	O
operating	O
room	O
on	O
___	O
where	O
she	O
underwent	O
an	O
Re-do	O
Sternotomy,	O
Mitral	O
valve	O
replacement	O
with	O
a	O
___	O
29	O
mm	O
Epic	O
tissue	O
valve,	O
serial	O
#___,	O
reference	O
___.	O
The	O
cardiopulmonary	O
bypass	O
time	O
was	O
101	O
minutes	O
with	O
a	O
cross	O
clamp	O
of	O
58	O
minutes.	O
She	O
tolerated	O
the	O
operation	O
well	O
and	O
following	O
surgery	O
he	O
was	O
transferred	O
to	O
the	O
CVICU	O
for	O
invasive	O
monitoring	O
in	O
stable	O
condition.	O
Her	O
AICD	O
was	O
interrogated	O
and	O
activated.	O
She	O
remained	O
hemodynamically	O
stable,	O
sedation	O
was	O
weaned,	O
she	O
awoke	O
neurologically	O
intact	O
and	O
was	O
extubated.	O
All	O
other	O
tubes,	O
lines	O
and	O
drains	O
were	O
removed	O
per	O
cardiac	O
surgery	O
protocol	O
without	O
complication.	O
She	O
was	O
started	O
on	O
Beta-blockers,	O
diuretics	O
and	O
these	O
were	O
titrated	O
as	O
needed.	O
Her	O
anticoagulation	O
for	O
chronic	O
atrial	O
fibrillation	O
was	O
resumed.	O
She	O
transitioned	O
from	O
an	O
insulin	O
drip	O
to	O
SQ	O
with	O
good	O
blood	O
sugar	O
control.	O
On	O
POD1	O
she	O
was	O
transferred	O
from	O
the	O
ICU	O
to	O
the	O
stepdown	O
floor	O
for	O
continued	O
recovery.	O
The	O
patient	O
was	O
evaluated	O
by	O
the	O
physical	O
therapy	O
service	O
for	O
assistance	O
with	O
strength	O
and	O
mobility.	O
By	O
the	O
time	O
of	O
discharge	O
on	O
POD	O
4	O
the	O
patient	O
was	O
ambulating	B-Independently_mobile
freely,	B-Independently_mobile
the	O
wound	O
was	O
healing	O
and	O
pain	O
was	O
controlled	O
with	O
oral	O
analgesics.	O
The	O
patient	O
was	O
discharged	O
to	O
home	O
with	O
___	O
of	O
___	O
in	O
good	O
condition	O
with	O
appropriate	O
follow	O
up	O
instructions.	O
Medications	O
on	O
Admission:	O
Digoxin	O
0.125	O
mg	O
daily	O
Gabapentin	O
100	O
mg	O
twice	O
daily	O
Insulin	O
Glargine	O
50	O
units	O
at	O
bedtime	O
Isosorbide	O
Mononitrate	O
ER	O
30	O
mg	O
daily	O
Metoprolol	O
succinate	O
50	O
mg	O
daily	O
Levothyroine	O
100	O
mcg	O
daily	O
Pantoprazole	O
40	O
mg	O
twice	O
daily	O
Potassium	O
Chloride	O
10	O
mEq	O
three	O
times	O
a	O
day	O
Repaglinide	O
1	O
mg	O
daily	O
Torsemide	O
60	O
mg	O
twice	O
daily	O
Warfarin	O
1	O
mg	O
___,	O
2	O
mg	O
___	O
Aspirin	O
81	O
mg	O
daily	O
Coenzyme	O
Q10	O
daily	O
Magnesium	O
Oxide	O
400	O
mg	O
bedtime	O
Sennosides	O
8.6	O
2	O
tablets	O
at	O
bedtime	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
325-650	O
mg	O
PO	O
Q6H:PRN	O
pain	O
2.	O
Aspirin	O
EC	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Colchicine	O
0.3	O
mg	O
PO	O
DAILY	O
4.	O
Glargine	O
30	O
Units	O
Bedtime	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
REG	O
Insulin	O
5.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
6.	O
Torsemide	O
60	O
mg	O
PO	O
BID	O
7.	O
Warfarin	O
0	O
mg	O
PO	O
DAILY16	O
2	O
mg	O
___	O
1	O
mg	O
___	O
8.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
9.	O
Metoprolol	O
Tartrate	O
50	O
mg	O
PO	O
BID	O
RX	O
*metoprolol	O
tartrate	O
50	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
twelve	O
(12)	O
hours	O
Disp	O
#*60	O
Tablet	O
Refills:*3	O
10.	O
Potassium	O
Chloride	O
20	O
mEq	O
PO	O
BID	O
11.	O
Sucralfate	O
1	O
gm	O
PO	O
BID	O
12.	O
Magnesium	O
Oxide	O
400	O
mg	O
PO	O
QHS	O
13.	O
Senna	O
8.6	O
mg	O
PO	O
HS	O
14.	O
Repaglinide	O
1	O
mg	O
PO	O
DAILY	O
15.	O
Gabapentin	O
100	O
mg	O
PO	O
BID	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
-	O
Systolic	O
congestive	O
heart	O
failure	O
___:	O
EF	O
35%	O
-	O
Mitral	O
regurgitation	O
___	O
-	O
Coronary	O
artery	O
disease,	O
NSTEMI	O
___	O
s/p	O
CABG	O
x	O
___,	O
s/p	O
multiple	O
PCIs,	O
mostly	O
to	O
LAD	O
*	O
___:	O
NSTEMI	O
s/p	O
coronary	O
atherectomies	O
to	O
LAD/D1	O
bifurcation	O
lesion	O
with	O
placment	O
of	O
2	O
stents	O
and	O
PTCA	O
to	O
jailed	O
D1	O
*	O
___:	O
Elective	O
cath	O
revealed	O
in-stent	O
restenosis	O
and	O
90Ã‘	O
restenosis;	O
PTCRA	O
was	O
performed	O
for	O
in-stent	O
restenosis	O
as	O
well	O
as	O
kissing	O
balloons	O
to	O
LAD/D1	O
with	O
residual	O
20%	O
D1	O
lesion	O
*	O
___:	O
UA	O
with	O
cath/no	O
intervention	O
but	O
LVEDP	O
38	O
*	O
___:	O
Chest	O
pain	O
with	O
diagnostic	O
cath	O
showing	O
widely	O
patent	O
LIMA-LAD	O
and	O
SVG-D1-OM1.	O
LMCA	O
with	O
50%	O
stenosis,	O
LAD	O
with	O
80%	O
proximal	O
and	O
mid,	O
LCx	O
with	O
70-80%	O
proximal,	O
and	O
RCA	O
with	O
80%	O
ostial	O
lesion.	O
LVEDP	O
severely	O
elevated	O
to	O
36	O
mmHg.	O
*	O
RHC	O
on	O
___	O
showed	O
mean	O
wedge	O
of	O
20	O
and	O
CO	O
of	O
2.871	O
L/min	O
-	O
PACING/ICD:	O
-	O
___	O
Hx	O
NSVT	O
on	O
telemetry	O
in	O
the	O
setting	O
of	O
MI,	O
sustained	O
T-wave	O
alternans	O
on	O
stress	O
testing	O
(worked	O
up	O
for	O
ICD	O
but	O
none	O
placed)	O
-	O
s/p	O
AICD	O
-	O
BiV	O
pacer	O
___	O
-	O
Chronic	O
atrial	O
fibrillation,	O
on	O
Coumadin	O
-	O
Peripheral	O
vascular	O
disease	O
-	O
Diabetes	O
mellitus	O
-	O
Hypothyroidism	O
-	O
Nephrolithiasis	O
(s/p	O
right	O
nephrectomy,	O
creatinine	O
1.1-1.4	O
baseline)	O
-	O
Plantar	O
fasciitis	O
-	O
Reflux	O
esophagitis,	O
peptic	O
ulcer	O
disease,	O
GERD	O
-	O
GI	B-Lower_gastrointestinal_haemorrhage
Bleed	B-Lower_gastrointestinal_haemorrhage
___	O
-	O
Peripheral	O
neuropathy	O
Past	O
Surgical	O
History:	O
-	O
s/p	O
CABG	O
x	O
___	O
-	O
s/p	O
right	O
nephrectomy	O
-	O
s/p	O
AICD	O
-	O
BiV	O
pacer	O
___	O
-	O
s/p	O
right	O
inguinal	O
hernia	O
operations	O
x	O
___	O
-	O
s/p	O
laparoscopic	O
cholecystectomy	O
___	O
___)	O
-	O
s/p	O
hysterectomy	O
Discharge	O
Condition:	O
Alert	O
and	O
oriented	B-Delirium
x3	B-Delirium
nonfocal	O
Ambulating,	B-Independently_mobile
gait	O
steady	O
Sternal	O
pain	O
managed	O
with	O
oral	O
analgesics	O
Sternal	O
Incision	O
-	O
healing	O
well,	O
no	O
erythema	O
or	O
drainage	O
Discharge	O
Instructions:	O
1.	O
Please	O
shower	O
daily	O
including	O
washing	O
incisions	O
gently	O
with	O
mild	O
soap,	O
no	O
baths	O
or	O
swimming,	O
and	O
look	O
at	O
your	O
incisions	O
2).	O
Please	O
NO	O
lotions,	O
cream,	O
powder,	O
or	O
ointments	O
to	O
incisions	O
3).	O
Each	O
morning	O
you	O
should	O
weigh	O
yourself	O
and	O
then	O
in	O
the	O
evening	O
take	O
your	O
temperature,	O
these	O
should	O
be	O
written	O
down	O
on	O
the	O
chart	O
4).	O
No	O
driving	O
for	O
approximately	O
one	O
month	O
and	O
while	O
taking	O
narcotics,	O
will	O
be	O
discussed	O
at	O
follow	O
up	O
appointment	O
with	O
surgeon	O
when	O
you	O
will	O
be	O
able	O
to	O
drive	O
5).	O
No	O
lifting	O
more	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O
6).	O
Please	O
wear	O
bra	O
to	O
reduce	O
pulling	O
on	O
incision,	O
avoid	O
rubbing	O
on	O
lower	O
edge	O
**Please	O
call	O
cardiac	O
surgery	O
office	O
with	O
any	O
questions	O
or	O
concerns	O
___.	O
Answering	O
service	O
will	O
contact	O
on	O
call	O
person	O
during	O
off	O
hours**	O
Followup	O
Instructions:	O
___	O

